Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Sarcoma 3Sarcoma, Ewing 1Osteosarcoma 1

Interventions

Doxorubicin 142Ifosfamide 85Radiotherapy 82Cyclophosphamide 72Gemcitabine 63Filgrastim 54pembrolizumab 43pazopanib 40Etoposide 39Docetaxel 39Vincristine 37Trabectedin 37Cisplatin 35Nivolumab 32Magnetic Resonance Spectroscopy 26Irinotecan 26Carboplatin 25Surgical Procedures, Operative 24Temozolomide 23Radiation 22Ipilimumab 22Bevacizumab 20Blood Specimen Collection 19Granulocyte Colony-Stimulating Factor 18Biopsy 18eribulin 17anlotinib 17Sirolimus 17Mesna 17Melphalan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Sarcoma × fluzoparib × Sarcoma × Clear all
NCT05938374 2025-12-11

SPARE-03

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Completed
52 enrolled
Sarcoma

Sarcoma

NCT05894018 2025-05-13

RAFAS-001

Sun Yat-sen University

Phase 2 Recruiting
32 enrolled
Sarcoma

Sarcoma

NCT06074692 2023-10-31

PRIMA

Ruijin Hospital

Phase 2 Recruiting
86 enrolled
Sarcoma

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡